Patents Assigned to AIVITA BIOMEDICAL, INC.
  • Use of cell membrane-bound signaling factors
    Patent number: 11666522
    Abstract: Disclosed herein are compositions comprising complexes of cyclodextrins and lipid-modified stem cell proteins. Also disclosed are topical compositions the complexes. Methods of using the compositions for the therapeutic purposes are also disclosed as well as methods of producing the compositions.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: June 6, 2023
    Assignee: AIVITA BIOMEDICAL, INC.
    Inventor: Gabriel Nistor